James M. Galloway, MD
https://reachmd.com/profiles/james-m-galloway-md/jlpxQj/
Dr. James M. Galloway is an Assistant US Surgeon General, Rear Admiral in the United States Public Health Service and Regional Health Administrator in Region V, Chicago, Ilinois. Dr. Galloway was appointed to the position of Regional Health Administrator in March, 2007 by the Assistant Secretary of…
Insulin Resistance and the Risk of Ischemic Stroke
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/insulin-resistance-and-the-risk-of-ischemic-stroke/6088/
Hundreds of millions of people may have insulin resistance worldwide. What is the connection between insulin resistance and the risk of ischemic stroke? Dr. Tatjana Rundek, associate professor of neurology and director of the clinical translational research division in the department of neurology of
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
https://reachmd.com/programs/heart-matters/cardiovascular-disease-in-t2d-researchers-identify-potential-therapeutic-target-for-underlying-cause/17999/
A newly identified therapeutic target may treat cardiovascular disease in T2D patients. Read more.
Investigating the T1D Increase: A Look at Rising Rates in Children Amid COVID-19
https://reachmd.com/programs/diabetes-discourse/investigating-the-t1d-increase-a-look-at-rising-rates-in-children-amid-covid-19/13528/
During the COVID-19 pandemic, T1D rates among children increased rapidly. Find out why.
Explore Impacts Of Glucose-Lowering Medications in Addition to Metformin
https://reachmd.com/programs/diabetes-discourse/explore-impacts-of-glucose-lowering-medications-in-addition-to-metformin/14620/
What did we learn about microvascular and cardiovascular impacts from glucose-lowering medication in combination with metformin?
Strategies for CV Risk Reduction in Complex T2D Patients
https://reachmd.com/programs/medical-industry-feature/strategies-for-cv-risk-reduction-in-complex-t2d-patients/14773/
Considerations clinicians should be aware of for patients who have both type 2 diabetes and a history of ASCVD. Dive in.
KDIGO Conversations in Nephrology - Programs
https://reachmd.com/programs/kdigo-conversations-nephrology/
KDIGO Conversations in Nephrology delivers high-yield updates on the diagnosis, treatment, and management of kidney disorders, from diabetes to glomerular diseases. With its short and easy-to-engage episodes of 15 to 30 minutes, this podcast series provides the latest news and expert insights on la…
William Howard, MD
https://reachmd.com/profiles/william-howard-md/Lyrg47/
A member of the ATP III panel and editor of the chapter on Lipoproteins and Atherosclerosis for the Year Book of Endocrinology, Dr. Howard is an endocrinologist specializing in lipidology, and a professor of medicine at the George Washington University School of Medicine and Health Sciences. In a…
Anastasia-Stefania Alexopoulos, MBBS, MHS
https://reachmd.com/profiles/anastasia-stefania-alexopoulos-mbbs-mhs/OKW8zK/
I am an endocrinologist and researcher who has a special interest in the care of patients with diabetes and metabolic disease. My goal is to provide the highest quality of care to my patients and to equip them with the knowledge and confidence needed to manage their health conditions. I believe it …
Taylor Grant
https://reachmd.com/profiles/taylor-grant/5LzpEj/
Taylor Grant is a health empowerment advocate and author of The 7 Questions That Will Save Your Life, The Pocket Health Organizer, The Women’s Essential Health Organizer, and The Diabetes Health Organizer. A recipient of the Gold Award for Health Promotion by the National Health Information Center,…